Simpson Thacher represented Barclays Capital, BofA Securities, Citigroup Global Markets Inc, SG Americas Securities Wells Fargo Securities, BNP Paribas Securities, DNB Markets, Goldman Sachs & Co. LLC, MUFG Securities Americas, RBC Capital Markets, Scotia Capital, TD Securities and U.S. Bancorp Investments who acted as underwriters on the deal.
Boston Scientific announced its cash tender offer for $2.85 billion aggregate principal amount, consisiting of outstanding 3.375% Senior Notes due 2022, 4.125% Senior Notes due 2023, 4.7% Senior Notes due 2049, 4.55% Senior Notes due 2039, 4% Senior Notes due 2029, 4% Senior Notes due 2028, 3.85% Senior Notes due 2025, 3.75% Senior Notes due 2026 and 3.45% Senior Notes due 2024.
Boston Scientific, as a global medical technology leader for over 40 years, advances science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
The Simpson Thacher team for the transaction included Roxane Reardon (Picture), Patrick Baron, Carlie Marks and Daniel Westen (Capital Markets); Jonathan Cantor and Edward Grais (Tax); Lori Lesser and Alysha Sekhon (Intellectual Property); Vanessa Burrows (Healthcare); Michael Isby (Environmental); Jeanne Annarumma and Brian Chung (ECEB); and Jennie Getsin (FINRA/Blue Sky).
Involved fees earner: Jeanne Annarumma – Simpson Thacher & Bartlett; Patrick Baron – Simpson Thacher & Bartlett; Vanessa Burrows – Simpson Thacher & Bartlett; Jonathan Cantor – Simpson Thacher & Bartlett; Brian Chung – Simpson Thacher & Bartlett; Jennie Getsin – Simpson Thacher & Bartlett; Edward Grais – Simpson Thacher & Bartlett; Michael Isby – Simpson Thacher & Bartlett; Lori Lesser – Simpson Thacher & Bartlett; Carlie Marks – Simpson Thacher & Bartlett; Roxane Reardon – Simpson Thacher & Bartlett; Alysha Sekhon – Simpson Thacher & Bartlett; Daniel Westen – Simpson Thacher & Bartlett;
Law Firms: Simpson Thacher & Bartlett;
Clients: Barclays Bank; BNP Paribas Securities; BofA Securities India Limited (DSP Merrill Lynch Limited); Citigroup Global Markets Ltd; DNB Markets; Goldman Sachs & Co.; MUFG Securities Americas Inc. ; RBC Capital Markets; Scotia Capital Inc.; SG Americas Securities LLC; TD Securities; US Bancorp Investments Inc.; Wells Fargo Securities;